Big Pharma could face losses if the newly split government can reach a consensus on drug prices
Share Now on:
There is already public consensus that drug prices are too high. Both Democrats and President Donald Trump have vowed to lower them. Yet, even with a new Democratic majority in the House, they may face challenges lowering pharmaceutical costs. Politically divided governments are often synonymous with gridlock, even on an issue as widely supported as drug prices. For their part, markets are signaling a belief in continued gridlock.
Marketplace is on a mission.
We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.
Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?